200
Views
0
CrossRef citations to date
0
Altmetric
TURNER SYNDROME AND CUSHING DISEASE: THE COEXISTENCE WITH OVERLAPPING COMPLICATIONS

Turner syndrome and Cushing disease – the coexistence with overlapping complications: case report and literature review

, , , &
Pages 1015-1020 | Received 18 Mar 2019, Accepted 10 Jun 2019, Published online: 27 Jun 2019

References

  • Bolanowski M, Łomna-Bogdanov E, Kosmala W, et al. Turner’s syndrome followed by acromegaly in the third decade of life: an unusual coincidence of two rare conditions. Gynecol Endocrinol. 2002;16:331–334.
  • Yamazaki M, Sato A, Nishio S, et al. Acromegaly accompanied by Turner syndrome with 47,XXX/45,X/46,XX mosaicism. Intern Med. 2009;48:447–453.
  • Sybert VP, McCauley E. Turner's syndrome. N Engl J Med. 2004;351:1227–1238.
  • Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177:G1–G70.
  • Elsheikh M, Dunger DB, Conway GS, et al. Turner's syndrome in adulthood. Endocr Rev. 2002;23:120–140.
  • Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88:5593–5602.
  • Gravholt CH, Juul S, Naeraa RW, et al. Morbidity in Turner syndrome. J Clin Epidemiol. 1998;51:147–158.
  • Gravholt CH, Naeraa RW, Nyholm B, et al. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner’s syndrome. The impact of sex hormone replacement. Diabetes Care. 1998;21:1062–1070.
  • Elsheikh M, Conway GS. The impact of obesity on cardiovascular risk factors in Turner's syndrome. Clin Endocrinol (Oxf). 1998;49:447–450.
  • Ostberg JE, Donald AE, Halcox JP, et al. Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab. 2005;90:5161–5166.
  • Shah S, Nguyen H, Vincent AJ. Care of the adult woman with Turner syndrome. Climacteric. 2018;21:428–436.
  • Taskinen MR, Nikkila EA, Pelkonen R, et al. Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing’s syndrome. J Clin Endocrinol Metab. 1983;57:619–626.
  • Gravholt CH, Hjerrild BE, Mosekilde L, et al. Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol. 2006;155:583–592.
  • Okamoto S, Morimoto Y, Reza MS, et al. Cerebral hemorrhage in Turner syndrome: a case report. Clin Pediatr Endocrinol. 2005;14:35–37.
  • Finsterer J, Zartl M, Samec P. Spontaneous cerebral haemorrhage without hypertension in non-mosaic 45,X Turner’s syndrome. J Clin Neurosci. 2000;7:341–343.
  • Nishida I, Katayama S, Hirata K, et al. Turner’s syndrome with cerebrovascular disorder. Jpn J Stroke. 1992;14:627–632.
  • Prockop DJ, Kivirikko KI, Tuderman L, et al. The biosynthesis of collagen and its disorders (second of two parts). N Engl J Med. 1979;301:77–85.
  • Stepan JJ, Musilova J, Pacovsky V. Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner’s syndrome. J Bone Miner Res. 1989;4:193–198.
  • Davies MC, Gulekli B, Jacobs HS. Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea. Clin Endocrinol (Oxf). 1995;43:741–746.
  • Sylven L, Hagenfeldt K, Ringertz H. Bone mineral density in middle-aged women with Turner's syndrome. Eur J Endocrinol. 1995;132:47–52.
  • Bakalov VK, Chen ML, Baron J, et al. Bone mineral density and fractures in Turner syndrome. Am J Med. 2003;115:259–264.
  • Prentice A, Parsons TJ, Cole TJ. Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am J Clin Nutr. 1994;60:837–842.
  • Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, et al. A longitudinal study on bone mineral density until adulthood in girls with Turner’s syndrome participating in a growth hormone injection frequency-response trial. Clin Endocrinol. 2000;52:531–536.
  • Toth M, Grossman A. Glucocorticoid-induced osteoporosis: lessons from Cushing’s syndrome. Clin Endocrinol. 2013;79:1–11.
  • Manning PJ, Evans MC, Reid IR. Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol (Oxf). 1992;36:229–234.
  • Silva BC, Leslie WD, Resch H, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res. 2014;29:518–530.
  • Nguyen HH, Wong P, Strauss B, et al. A cross-sectional and longitudinal analysis of trabecular bone score in adults with Turner syndrome. J Clin Endocrinol Metab. 2018;103:3792–3800.
  • Szappanos Á, Tőke J, Lippai D, et al. Bone turnover in patients with endogenous Cushing’s syndrome before and after successful treatment. Osteoporos Int. 2010;21:637–645.
  • Kristo C, Jemtland R, Ueland T, et al. Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing’s syndrome: a prospective, long-term study. Eur J Endocrinol. 2006;154:109–118.
  • Roulot D. Liver involvement in Turner syndrome. Liver Int. 2013;33:24–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.